Top Banner
GANGRENE ON LEFT GREAT TOE, DIABETES MELLITUS 2 AND HYPERTENSION Amarnath Mullapudi 14PPM2037 NIPER-Mohali 1
22
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Case presentation on diabetic foot

GANGRENE ON LEFT

GREAT TOE, DIABETES

MELLITUS 2 AND

HYPERTENSION

Amarnath Mullapudi

14PPM2037

NIPER-Mohali1

Page 2: Case presentation on diabetic foot

Chief complaints

2

Wound on left great toe x 1 month

Pain of left foot x 2 month

Bleeding of left great toe x 1 month

Page 3: Case presentation on diabetic foot

Past history

3

K/C/O of colitis and gastric bleeding

Diabetes mellitus type 2

Hypertension

Chronic kidney disease

Page 4: Case presentation on diabetic foot

Patient details

4

Age : 81 years

Sex : Female

Weight : 68 kgs

BP : 140/90 mmHg

HR : 80 beats/minute

RR : 22/minute

Page 5: Case presentation on diabetic foot

Laboratory investigations

5

Page 6: Case presentation on diabetic foot

Lab investigation - 1

6

PARAMETER DAYS

Hb

12-18 gm%

D1 D3 D5 D7 D8

10.1 9.0 - 8.1 -

D9 D10 D12 D14 D15

8.8 8.1 - 9.7 -

Platelets (×103)

1.5-4lakhs/µl

D1 D3 D5 D7 D8

523 477 - 494 -

D9 D10 D12 D14 D15

581 588 - 602 -

Page 7: Case presentation on diabetic foot

Lab investigation - 2

7

PARAMETER DAYS

Prothrombin

time

(Control 13 secs)

D1 D3 D5 D7 D8

18 17 - 15 17

D9 D10 D12 D14 D15

- 17 - - 17

PT Index (%)

D1 D3 D5 D7 D8

72 76 - 86 76

D9 D10 D12 D14 D15

- 76 - - 76

Page 8: Case presentation on diabetic foot

Lab investigation - 3

8

PARAMETER DAYS

INR

0.8-1.4

D1 D3 D5 D7 D8

1.35 1.3 - 1.16 1.3

D9 D10 D12 D14 D15

1.3 - - - 1.28

TLC (×102)

4-10.5 k/mm3

D1 D3 D5 D7 D8

114 145 - 131 -

D9 D10 D12 D14 D15

122 120 - 101 -

Page 9: Case presentation on diabetic foot

Lab investigation - 4

9

PARAMETER DAYS

Na+

135-145mEq/L

D1 D3 D5 D7 D8

132 130 136 137 137

D9 D10 D12 D14 D15

136 137 130 - 130

K+

3.5-5.2mEq/L

D1 D3 D5 D7 D8

4.2 4.1 3.9 3.7 4.0

D9 D10 D12 D14 D15

3.9 3.9 4.2 - 4.5

Page 10: Case presentation on diabetic foot

Lab investigation - 5

10

PARAMETER DAYS

Cl-

95-105mEq/L

D1 D3 D5 D7 D8

97.7 98 98 93.9 97.8

D9 D10 D12 D14 D15

116 100.1 98 - 99

Urea

10-50mg%

D1 D3 D5 D7 D8

31.9 31.9 26 19.7 17.7

D9 D10 D12 D14 D15

16 15.9 18 - 19

Page 11: Case presentation on diabetic foot

Lab investigation - 6

11

PARAMETER DAYS

Creatinine

0.6-1.2mg%

D1 D3 D5 D7 D8

3.3 3.3 3.2 3.2 2.8

D9 D10 D12 D14 D15

2.5 3.3 1.7 2.4 2.8

Ca++

8.5-10.5mg/dl

D1 D3 D5 D7 D8

9.6 9.8 8.9 9.2 9.5

D9 D10 D12 D14 D15

10.2 9.6 9.1 9.8 9.5

Page 12: Case presentation on diabetic foot

Lab investigation - 7

12

PARAMETER-- DAYS

Albumin

3.4-4.8gm/dl

D1 D3 D5 D7 D8

2.9 3.7 3.0 3.1 3.3

D9 D10 D12 D14 D15

- 3.1 - - -

Protein (T)

6.4-8.3gm/dl

D1 D3 D5 D7 D8

- 7.27 6.7 6.85 6.89

D9 D10 D12 D14 D15

- 6.96 - - -

Page 13: Case presentation on diabetic foot

Diagnosis

13

Gangrene on left toe with pain and bleeding

Diabetes mellitus type 2

Hypertension

Page 14: Case presentation on diabetic foot

Medication charts

14

Page 15: Case presentation on diabetic foot

Medication chart - 1

15

Drug ROA Dose Freq. Days

CefuroximePO 500mg OD D1-D6

Amoxicillin + Clavulinic

acid PO 625mg

12

hourlyD1-D15

Cefprozil PO 500mg BD D1-D6

Atrovostatin PO 20mg OD D1-D15

Valerian PO 40mg BD D1-D15

Page 16: Case presentation on diabetic foot

Medication chart - 2

16

Drug ROA Dose Freq. Days

Amlodipine PO 2.5mg OD D1-D15

Alprazolam PO 0.25mg TDS D4-D15

Telmisartan +

hydrochlorothiazidePO

40 &

12.5mgOD D4-D12

Erythropoietin SC 10,000

IU

weekly D1&D8

Tramadol + paracetamol PO37.5 &

325mgBD D6-D15

Page 17: Case presentation on diabetic foot

Medication chart - 3

17

Drug ROA Dose Freq. Days

Cilostazol PO 50mg TDS D3-D15

Acetaminophen + codeine PO650mg +

30mg8 hourly D1-D6

Metoprolol PO 12.5mg OD D1-D15

Becosule PO 1 cap OD D1-D15

Insulin R SC 15 U TDS D1-D15

Page 18: Case presentation on diabetic foot

Pharmaceutical issues

18

Drug duplication

Cefprozil and Cefuroxime two drugs of the same class are

administered.

Contraindication

Patient has a past history of colitis and gastric bleeding. Cefuroxime

and Cefprozil are contraindicated in this case.

Suggestion: Replace Cefuroxime with Clindamycin in the dose of

300mg BD. Clindamycin can be administered to the patients who has

severe skin and subcutaneous infections.

Source : Micromedex

Page 19: Case presentation on diabetic foot

Summary

19

A 81 years old female was admitted into the hospital

with the following complaints:

Pain and gangrene on the left great toe with bleeding.

She has history of DM-2 and hypertension.

She was diagnosed with gangrene on left great toe.

She was administered antihypertensives, antibiotics,

NSAIDs, anticoagulant, insulin and alprazolam.

Page 20: Case presentation on diabetic foot

Summary cont…

20

Pharmaceutical issues

Drug duplication of cephalosporin antibiotics

Contraindication; administration of cefprozil and

cefuroxime to the patient suffering from colitis.

Page 21: Case presentation on diabetic foot

References

21

Viswanathan V. Epidemiology of diabetic foot and

management of foot problems in India. Int J Low Extrem

Wounds. 2010;9:122–6.

Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC,

Chaudhry R. A clinico-microbiological study of diabetic foot

ulcers in an Indian tertiary care hospital. Diabetes

Care. 2006;29:1727–32.

Pendsey SP. Understanding diabetic foot. Int J Diabetes Dev

Ctries 2010 Jun;30(2):75–79.

Page 22: Case presentation on diabetic foot